Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma

Published:2017-06 Issue:5 Volume:33 Page:361-365
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Stahl Erin¹,Bremond-Gignac Dominique²,Landry Theresa³,Curtis Mike³,Gedif Kinfemichael³,Al Shahwan Sami⁴,Dixon El Roy⁵

Affiliation:

1. Children's Mercy Hospital, Kansas City, Missouri.

2. University Hospital Necker Enfants-Malades, Paris, France.

3. Alcon Laboratories, Inc., Fort Worth, Texas.

4. King Khaled Eye Specialists Hospital, Riyadh, Kingdom of Saudi Arabia.

5. Dixon Eye Care, Albany, Georgia.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2016.0133

Reference12 articles.

1. Pharmacologic Management of Glaucoma in Childhood

2. Understanding the Importance of IOP Variables in Glaucoma: A Systematic Review

3. ComparativeIn VitroToxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells

4. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication

5. Travoprost in children: Adverse effects and intraocular pressure response

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically Relevant OATP2B1 Inhibitors in Marketed Drug Space;Molecular Pharmaceutics;2020-01-02

2. A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension;Journal of American Association for Pediatric Ophthalmology and Strabismus;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3